Cytotoxic Effects of Nanoliposomal Cisplatin and Diallyl Disulfide on Breast Cancer and Lung Cancer Cell Lines

Dual drug delivery has become the choice of interest nowadays due to its increased therapeutic efficacy in targeting the tumor site precisely. As quoted in recent literature, it has been known to treat several cancers with an acute course of action. Even so, its use is restricted due to the drug’s l...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Kaavya Gunasekaran, Bala Murali Krishna Vasamsetti, Priyadharshini Thangavelu, Karthi Natesan, Bonaventure Mujyambere, Viswanathan Sundaram, Rama Jayaraj, Yeon-Jun Kim, Suja Samiappan, Jae-Won Choi
Format:	Artigo
Język:	Inglês
Wydane:	MDPI AG 2023-03-01
Seria:	Biomedicines
Hasła przedmiotowe:	nanoliposome cisplatin diallyl disulfide anti-cancer therapy
Dostęp online:	https://www.mdpi.com/2227-9059/11/4/1021
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!